Preclinical CRO Market: How Is the Biologic Drug Pipeline Driving Specialized CRO Demand?
Biologic and advanced therapy preclinical services — the specialized immunogenicity assessment, large molecule ADME, gene therapy biodistribution, CAR-T cell characterization, and complex modality safety testing requiring CRO capabilities beyond traditional small molecule services — represent the fastest-growing and highest-complexity preclinical CRO market segment, with the...
0 Commenti 0 condivisioni 5 Views 0 Anteprima